A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

NCT05052307 · clinicaltrials.gov ↗

COMPLETED

Status

4574

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
DRUG: CoronaVac COVID-19 vaccine
DRUG: ChAdOx1 nCoV-19 Covid-19 Vaccine
DRUG: Ad26.COV2.S COVID-19 Vaccine

Sponsor

Hospital Moinhos de Vento

Collaborators

[object Object]
[object Object]
[object Object]